Open AccessEpistaxis management on COVID‐19–positive patients: Our early case experience and treatment
Author(s) -
Bathula Samba Siva R.,
Patrick Tyler,
Srikantha Luxman
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3137
Subject(s) - medicine , covid-19 , oxymetazoline , transmission (telecommunications) , respiratory system , nasal decongestant , healthcare worker , intensive care medicine , anesthesia , health care , disease , pathology , infectious disease (medical specialty) , adrenergic receptor , receptor , outbreak , economic growth , electrical engineering , economics , engineering
Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID‐19 transmission to surrounding healthcare workers.